{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:11:58Z","timestamp":1753891918007,"version":"3.41.2"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Glycogen storage diseases (GSDs) are a group of hereditary metabolic disorders with variable clinical manifestations, depending on the enzyme and organ affected. Renal dysfunction, including hyperfiltration, proteinuria, and renal tubular acidosis (RTA), is a known complication, particularly in GSD types of Ia and Ib.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This cross-sectional study evaluated renal function in 17 pediatric patients with different GSD types using an integral kidney assessment (IKA). The comprehensive evaluation included biochemical and urinary analyses, glomerular filtration rate calculations, and acidification tests.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The median age at first renal evaluation was 33\u2005months, and nutritional management was often suboptimal at this stage. Through IKA, renal alterations were identified in 47% of the patients. Hyperfiltration was present in 40% of GSD type I patients, while lactic acidosis was noted in 30% of these cases. Two siblings with GSD XI presented with proximal RTA and Fanconi syndrome, highlighting severe tubular involvement. Distal RTA was documented in one non-adherent GSD Ia patient, underscoring the importance of metabolic control.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This study emphasizes the heterogeneity of renal manifestations among different GSD subtypes. Hyperfiltration, particularly in GSD I, may result from altered energy metabolism and compensatory mechanisms within the renal tubules. Proximal tubular damage in GSD XI reflects glycogen and monosaccharide accumulation within renal epithelial cells. Adherence to dietary and medical interventions is critical for mitigating renal complications and ensuring growth and development in GSD patients. Annual kidney evaluations are recommended for early detection of renal dysfunction, enabling timely initiation of therapeutic strategies such as alkali therapy and angiotensin-converting enzyme inhibitors.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2025.1543164","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:31:43Z","timestamp":1745818303000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Integral kidney function assessment in pediatric patients with glycogen storage diseases"],"prefix":"10.3389","volume":"13","author":[{"given":"Magali","family":"Reyes-Apodaca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Consuelo-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"V\u00e1zquez-Frias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjam\u00edn Antonio","family":"Rodr\u00edguez-Espino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1023\/a:1005346824368","article-title":"Metabolic control and renal dysfunction in type I glycogen storage disease","volume":"20","author":"Wolfsdorf","year":"1997","journal-title":"J Inherit Metab Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/BF00852851","article-title":"Type I glycogen storage disease: kidney involvement, pathogenesis and its treatment","volume":"5","author":"Chen","year":"1991","journal-title":"Pediatr Nephrol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.jpeds.2014.12.015","article-title":"Progression of renal damage in glycogen storage disease type I is associated to hyperlipidemia: a multicenter prospective Italian study","volume":"166","author":"Melis","year":"2015","journal-title":"J Pediatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fped.2020.00591","article-title":"Kidney and metabolic phenotypes in glycogen storage disease type-I patients","volume":"8","author":"Aoun","year":"2020","journal-title":"Front Pediatr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"6286","DOI":"10.3390\/ijms21176286","article-title":"Fanconi-Bickel syndrome: a review of the mechanisms that lead to dysglycaemia","volume":"21","author":"Sharari","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/j.1651-2227.1979.tb18458.x","article-title":"Case report renal tubular acidosis associated with type III glycogenosis","volume":"68","author":"Cohen","year":"1979","journal-title":"Acta Paediatr Scand"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s00467-015-3083-9","article-title":"Clinical and laboratory approaches in the diagnosis of renal tubular acidosis","volume":"30","author":"Santos","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.2215\/cjn.00050109","article-title":"Renal function in glycogen storage disease type I, natural course, and renopreservative effects of ACE inhibition","volume":"4","author":"Martens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/ki.1989.133","article-title":"Hyperfiltration and renal disease in glycogen storage disease, type I","volume":"35","author":"Baker","year":"1989","journal-title":"Kidney Int"},{"key":"B10","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s10545-017-0054-2","article-title":"Tight metabolic control plus ACE inhibitor therapy improves GSD I nephropathy","volume":"40","author":"Okechuku","year":"2017","journal-title":"J Inherit Metab Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"100765","DOI":"10.1016\/j.ymgmr.2021.100765","article-title":"Profound neonatal lactic acidosis and renal tubulopathy in a patient with glycogen storage disease type IX\u02512 secondary to a de novo pathogenic variant in PHKA2","volume":"27","author":"Morales","year":"2021","journal-title":"Mol Genet Metab Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"434","DOI":"10.24953\/turkjped.2017.04.010","article-title":"Impaired glucose tolerance in Fanconi-Bickel syndrome: eight patients with two novel mutations","volume":"59","author":"\u015eeker-Y\u0131lmaz","year":"2017","journal-title":"Turk J Pediatr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-022-02387-6","article-title":"Glycogen storage diseases with liver involvement: a literature review of GSD type 0, IV, VI, IX and XI","volume":"17","author":"Massese","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1681\/ASN.2021070935","article-title":"Dapagliflozin prevents kidney glycogen accumulation and improves renal proximal tubule cell functions in a mouse model of glycogen storage disease type 1b","volume":"33","author":"D\u2019Acierno","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"eabn4214","DOI":"10.1126\/scitranslmed.abn4214","article-title":"The SGLT2 inhibitor dapagliflozin improves kidney function in glycogen storage disease XI","volume":"15","author":"Trepiccione","year":"2023","journal-title":"Sci Transl Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/jimd.12752","article-title":"Repurposing SGLT2 inhibitors: treatment of renal proximal tubulopathy in Fanconi-Bickel syndrome with empagliflozin","volume":"47","author":"Overduin","year":"2024","journal-title":"J Inherit Metab Dis"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1543164\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:31:44Z","timestamp":1745818304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1543164\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":16,"alternative-id":["10.3389\/fped.2025.1543164"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1543164","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"article-number":"1543164"}}